Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02411123 · ClinicalTrials.gov registry record · NA

Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders

A NA study of Depression and Anxiety, sponsored by AltheaDx.

Completed
Registry status
NA
Development phase
220
Enrollment target
1
Study location

NCT02411123 is a NA study of Depression and Anxiety that has completed, run by AltheaDx. The registered enrollment target is 220 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02411123, a NA study of Depression and Anxiety, has completed, sponsored by AltheaDx.

COMPLETED
Registry status
NA
Development phase
220 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effect of pharmacogenetic (PGx) testing on clinical outcomes in a group of subjects exhibiting neuropsychiatric disorders, such as depression and anxiety, as compared to a group of subjects with the same attributes without the guidance of PGx testing for their treatment. This study will also evaluate whether pharmacogenetic (PGx) testing can reduce adverse drug events, hospitalization rates, hospital length of stay, emergency room visits, disability, death or other serious drug side effects.

Conditions Studied

Depression Anxiety

Interventions

  • GENETIC IDgenetix Neuropsychiatric Test Panel

Study Locations (1)

North Carolina

  • Carolina Partners in Mental HealthCare - Raleigh

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2015-03
Est. Completion 2015-12
Phase NA

Sponsor

AltheaDx

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02411123

The ClinicalTrials.gov registry entry for NCT02411123 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (72% lower). The listed sponsor is AltheaDx, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which IDgenetix Neuropsychiatric Test Panel is the first listed.

NCT02411123 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02411123 about?

NCT02411123 is a clinical study titled "Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders". The purpose of this study is to evaluate the effect of pharmacogenetic (PGx) testing on clinical outcomes in a group of subjects exhibiting neuropsychiatric disorders, such as depression and anxiety, as compared to a group of subjects with the same attributes without the guidance of PGx testing for ...

What is the current status of trial NCT02411123?

This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2015-03. Estimated completion is 2015-12.

What conditions does trial NCT02411123 study?

This clinical trial studies the following conditions: Depression, Anxiety.

What interventions are being tested in trial NCT02411123?

The interventions under investigation include: IDgenetix Neuropsychiatric Test Panel (GENETIC).

Who is sponsoring clinical trial NCT02411123?

This trial is sponsored by AltheaDx, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02411123 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Depression

All registered trials for this condition

Anxiety

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.